Efficacy and Safety of Alirocumab in Japanese Patients with Diabetes Mellitus: Post-hoc Subanalysis of ODYSSEY Japan

Aim: To examine the efficacy and safety of alirocumab in Japanese patients with dyslipidemia with or without diabetes mellitus (DM). Methods: Patients (n = 216) with heterozygous familial hypercholesterolemia (heFH), non-FH at high cardiovascular risk with coronary artery disease (CAD), or category...

Descripción completa

Detalles Bibliográficos
Autores principales: Teramoto, Tamio, Usami, Makiko, Takagi, Yoshiharu, Baccara-Dinet, Marie T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402882/
https://www.ncbi.nlm.nih.gov/pubmed/30068817
http://dx.doi.org/10.5551/jat.45070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402882/
https://www.ncbi.nlm.nih.gov/pubmed/30068817
http://dx.doi.org/10.5551/jat.45070

Ejemplares similares